海角社区 and Our Lady of the Lake Health Pioneer New Sepsis Test, Saving Lives, Cost

April 29, 2024

Setting a Gold Standard in Sepsis Care

In hospitals nationwide, more people die from sepsis than from anything else. It鈥檚 more deadly than opioid overdoses, breast cancer and prostate cancer combined, and is the leading cause of hospital admission and readmission. It鈥檚 also one of the most difficult diseases to diagnose. But since August, a new sepsis test based on 海角社区 and Our Lady of the Lake Health research and advances in microfluidics is saving lives and cost at Louisiana鈥檚 largest hospital.
 
Sepsis is an extreme overreaction to infection that can cause severe organ damage, making early detection critical. Now, in鈥10 minutes or less, patients and providers can see if a person鈥檚 white blood cells are getting ready to attack. More than 3,000 patients have been tested for sepsis at Our Lady of the Lake Health since the test was implemented last August. 
  
鈥淲e used to do the best we could,鈥 said Dr. Christopher Thomas, vice president and chief quality officer for Franciscan Missionaries of Our Lady Health System. 鈥淣ow, through translational research, we have a test that allows us to triage efficiently and effectively. We鈥檙e getting to where we鈥檙e pulling people out of the waiting room 60 minutes faster.鈥

鈥淲e鈥檙e also saving patients more than a full day in the hospital,鈥 said 海角社区 Associate Professor of Medicine Dr. Bud O鈥橬eal, medical director of research at Our Lady of the Lake Health, who led the nationwide research to develop the test.

海角社区 Health New Orleans鈥 Dr. Christopher Thomas and Dr. Bud O鈥橬eal

海角社区 Health New Orleans鈥 Dr. Christopher Thomas and Dr. Bud O鈥橬eal save lives and cost for patients and Our Lady of the Lake Health with a newly developed rapid sepsis test.

鈥 Elsa Hahne/海角社区

鈥淲hile we鈥檝e had the privilege of interacting with a number of universities, what鈥檚 been really special about the work with Dr. O鈥橬eal and 海角社区 has been their continuous focus on making sure the collaborative research and development we did together was always focused on patient needs. They鈥檝e been the best partner we could have asked for.鈥

Ajay Shah, CEO, Cytovale